201 related articles for article (PubMed ID: 23351390)
1. Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.
Yu B; Dong J; Wang C; Zhan Y; Zhang H; Wu J; Kong W; Yu X
Virology; 2013 Mar; 437(2):118-23. PubMed ID: 23351390
[TBL] [Abstract][Full Text] [Related]
2. Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.
Yu B; Dong J; Wang C; Wang Z; Gao L; Zhang H; Wu J; Kong W; Yu X
J Gen Virol; 2014 Jul; 95(Pt 7):1564-1573. PubMed ID: 24764358
[TBL] [Abstract][Full Text] [Related]
3. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
[TBL] [Abstract][Full Text] [Related]
4. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
[TBL] [Abstract][Full Text] [Related]
5. Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity.
Feng Y; Sun X; Ye X; Feng Y; Wang J; Zheng X; Liu X; Yi C; Hao M; Wang Q; Li F; Xu W; Li L; Li C; Zhou R; Chen L; Feng L
Virology; 2018 May; 518():272-283. PubMed ID: 29550678
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.
Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R
Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937
[TBL] [Abstract][Full Text] [Related]
9. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
10. Adenoviruses isolated from wild gorillas are closely related to human species C viruses.
Duncan M; Cranfield MR; Torano H; Kuete HM; Lee GP; Glenn A; Bruder JT; Rangel D; Brough DE; Gall JG
Virology; 2013 Sep; 444(1-2):119-23. PubMed ID: 23806387
[TBL] [Abstract][Full Text] [Related]
11. Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.
Cheng C; Wang L; Gall JG; Nason M; Schwartz RM; McElrath MJ; DeRosa SC; Hural J; Corey L; Buchbinder SP; Nabel GJ
PLoS One; 2012; 7(4):e33969. PubMed ID: 22496775
[TBL] [Abstract][Full Text] [Related]
12. Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.
Hu K; Fu M; Guan X; Zhang D; Deng X; Xiao Y; Chen R; Liu H; Hu Q
Vaccine; 2018 Jul; 36(29):4287-4297. PubMed ID: 29885770
[TBL] [Abstract][Full Text] [Related]
13. [Anti-adenovirus neutralizing antibodies and Gag-specific cellular immune responses in Macaca fascicularis immunized with Ad5-HIVgag].
Li Y; Yang L; Yang L; Chen DY; Feng X; Yu SQ; Li ZL; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):413-5. PubMed ID: 22734222
[TBL] [Abstract][Full Text] [Related]
14. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
[TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.
Bauer U; Flunker G; Bruss K; Kallwellis K; Liebermann H; Luettich T; Motz M; Seidel W
J Clin Microbiol; 2005 Sep; 43(9):4426-33. PubMed ID: 16145087
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts.
Gahéry-Ségard H; Juillard V; Gaston J; Lengagne R; Pavirani A; Boulanger P; Guillet JG
Eur J Immunol; 1997 Mar; 27(3):653-9. PubMed ID: 9079805
[TBL] [Abstract][Full Text] [Related]
17. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y
Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China.
Sun C; Zhang Y; Feng L; Pan W; Zhang M; Hong Z; Ma X; Chen X; Chen L
Vaccine; 2011 May; 29(22):3837-41. PubMed ID: 21447314
[TBL] [Abstract][Full Text] [Related]
20. Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients.
Raki M; Sarkioja M; Escutenaire S; Kangasniemi L; Haavisto E; Kanerva A; Cerullo V; Joensuu T; Oksanen M; Pesonen S; Hemminki A
J Gene Med; 2011 May; 13(5):253-61. PubMed ID: 21520358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]